ATE441713T1 - Tumorantigenprotein und dessen verwendung - Google Patents

Tumorantigenprotein und dessen verwendung

Info

Publication number
ATE441713T1
ATE441713T1 AT03798427T AT03798427T ATE441713T1 AT E441713 T1 ATE441713 T1 AT E441713T1 AT 03798427 T AT03798427 T AT 03798427T AT 03798427 T AT03798427 T AT 03798427T AT E441713 T1 ATE441713 T1 AT E441713T1
Authority
AT
Austria
Prior art keywords
tumor antigen
antigen protein
protein
same
inducer
Prior art date
Application number
AT03798427T
Other languages
English (en)
Inventor
Noriyuki Sato
Tomohide Tsukahara
Yuki Nabeta
Satoshi Kawaguchi
Hideyuki Ikeda
Takuro Wada
Toshihiko Yamashita
Original Assignee
Dainippon Sumitomo Pharma Co
Noriyuki Sato
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dainippon Sumitomo Pharma Co, Noriyuki Sato filed Critical Dainippon Sumitomo Pharma Co
Application granted granted Critical
Publication of ATE441713T1 publication Critical patent/ATE441713T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT03798427T 2002-09-27 2003-09-19 Tumorantigenprotein und dessen verwendung ATE441713T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2002282345 2002-09-27
PCT/JP2003/012037 WO2004029248A1 (ja) 2002-09-27 2003-09-19 腫瘍抗原タンパク質及びその利用

Publications (1)

Publication Number Publication Date
ATE441713T1 true ATE441713T1 (de) 2009-09-15

Family

ID=32040535

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03798427T ATE441713T1 (de) 2002-09-27 2003-09-19 Tumorantigenprotein und dessen verwendung

Country Status (7)

Country Link
US (2) US7700108B2 (de)
EP (1) EP1557466B1 (de)
JP (2) JP4484707B2 (de)
AT (1) ATE441713T1 (de)
AU (1) AU2003264535A1 (de)
DE (1) DE60329115D1 (de)
WO (1) WO2004029248A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE441713T1 (de) * 2002-09-27 2009-09-15 Dainippon Sumitomo Pharma Co Tumorantigenprotein und dessen verwendung
EP2363468B1 (de) * 2008-10-20 2014-12-31 Sapporo Medical University Tumorantigenpeptid und verwendung davon
JP6077641B2 (ja) * 2013-03-08 2017-02-08 大鵬薬品工業株式会社 新規ｃｔｌエピトープ５連結ペプチド
WO2014157704A1 (ja) * 2013-03-29 2014-10-02 大日本住友製薬株式会社 Ｅｒａｐ１によるトリミング機能をきっかけとしたコンジュゲートワクチン
DK2982681T3 (en) 2013-03-29 2018-12-10 Sumitomo Dainippon Pharma Co Ltd WT1 ANTIGENPEPTIDKONJUGATVACCINE
CN105658673B (zh) * 2013-10-21 2019-07-26 大鹏药品工业株式会社 新型的具有4个连接的ctl表位的肽
WO2018101309A1 (ja) 2016-11-30 2018-06-07 大日本住友製薬株式会社 Ｗｔ１ヘルパーペプチド及びこれと癌抗原ペプチドコンジュゲート体との組合せ
CN112368016A (zh) 2018-06-29 2021-02-12 大鹏药品工业株式会社 抗肿瘤剂及其评价方法
JPWO2024248120A1 (de) * 2023-05-31 2024-12-05

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6083513A (en) * 1993-11-16 2000-07-04 Gerbu Biotechnik Gmbh Method for increasing the yield of antibodies in the techniques of immunology
JP3509199B2 (ja) 1994-06-15 2004-03-22 日本油脂株式会社 乳化剤組成物およびそれを用いた油中水型エマルシヨンの調製方法
JP3752711B2 (ja) 1995-11-02 2006-03-08 日本油脂株式会社 水中油中水型エマルシヨンの調製方法
JP2002513295A (ja) * 1997-07-08 2002-05-08 ヒューマン・ジェノム・サイエンシズ・インコーポレイテッド １２３種類のヒト分泌タンパク質
WO1999003972A1 (en) * 1997-07-15 1999-01-28 Takara Shuzo Co., Ltd. Cytotoxic t lymphocytes
AU766787B2 (en) * 1998-01-23 2003-10-23 Beth Israel Deaconess Medical Center Meth1 and meth2 polynucleotides and polypeptides
WO2000032770A1 (fr) * 1998-12-01 2000-06-08 Sumitomo Pharmaceuticals Company, Limited Nouvelle proteine d'antigene tumoral art-1 et peptide d'antigene tumoral de cette derniere
US6635742B1 (en) * 2000-01-25 2003-10-21 Nuvelo, Inc. Antibodies specific for semaphorin-like polypeptides
JP2004509612A (ja) * 2000-06-05 2004-04-02 アバロン　ファーマシューティカルズ ガン遺伝子決定および特徴的な遺伝子群を用いた治療用スクリーニング
WO2002050103A2 (en) * 2000-12-20 2002-06-27 Glaxosmithkline Biologicals S.A. Tumour-related antigens
WO2002068579A2 (en) * 2001-01-10 2002-09-06 Pe Corporation (Ny) Kits, such as nucleic acid arrays, comprising a majority of human exons or transcripts, for detecting expression and other uses thereof
US7171311B2 (en) * 2001-06-18 2007-01-30 Rosetta Inpharmatics Llc Methods of assigning treatment to breast cancer patients
AU2002336564A1 (en) 2001-09-18 2003-04-01 Michigan Biotechnology Institute Method of enzyme production by microorganisms
ATE441713T1 (de) * 2002-09-27 2009-09-15 Dainippon Sumitomo Pharma Co Tumorantigenprotein und dessen verwendung

Also Published As

Publication number Publication date
JPWO2004029248A1 (ja) 2006-01-26
US20100255579A1 (en) 2010-10-07
EP1557466A1 (de) 2005-07-27
US7700108B2 (en) 2010-04-20
EP1557466B1 (de) 2009-09-02
JP5281515B2 (ja) 2013-09-04
JP4484707B2 (ja) 2010-06-16
US20080014636A1 (en) 2008-01-17
WO2004029248A1 (ja) 2004-04-08
JP2010000083A (ja) 2010-01-07
DE60329115D1 (de) 2009-10-15
AU2003264535A1 (en) 2004-04-19
EP1557466A4 (de) 2006-02-08

Similar Documents

Publication Publication Date Title
DE50112802D1 (de) Peptide, deren herstellung und verwendung zur bindung von immunglobulinen
AU2001290837A1 (en) Use of a polypeptide comprising the extracellular domains of il-20rb for the treatment of inflammation
CY1105616T1 (el) ΠΕΠΤΙΔΙΑ ΑΝΑΣΤΟΛΕΙΣ ΤΟΥ TGFβ1
WO2006023665A3 (en) Il-1 antagonist formulations
NO20073914L (no) Biologisk aktive peptider
ATE495247T1 (de) Chromoprotein und fluoroproteine
ATE441713T1 (de) Tumorantigenprotein und dessen verwendung
DE60228136D1 (de) Cytokin-proteinfamilie
ATE474589T1 (de) Angiogene peptide und ihre verwendungen
EP0816504A3 (de) Acetylhydrolase des Plättchen aktivierenden Faktors, und entsprechendes Gen
ATE514716T1 (de) Fragmente toxin-bezogener antikörper, mit antimikrobieller und antiviraler aktivität
DE60234843D1 (de) Modifizierte peptide und deren verwendung zur behandlung von autoimmunkrankheiten
NZ591827A (en) Biologically active peptides comprising PTTKTYFPHF and their uses in the manufacture of a medicament for modulating immune reaction in a radiotherapy-induced immuno-compromised subject
DE59108261D1 (de) Peptide des HIV-gag Proteins, ihre Herstellung und Verwendung
WO2004000870A3 (en) Two synthetic peptides for treatment and prevention of cancers
AU2003202489A1 (en) Screening method
SG170757A1 (en) Polypeptide having esterase activity and recombinant esterase and use thereof
WO2003018806A1 (fr) Nouveau gene humain bmcc1
WO2001025430A3 (en) Novel human membrane proteins
WO2004013167A3 (en) Purified polypeptides from enterococcus faecalis
CY1113593T1 (el) Σκευασματα ανταγωνιστη il-1
DE60135971D1 (de) Mit wt1 interagierendes protein, wtip

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties